Antiviral Activity of Oligomerization-Deficient Stat1

Uwe Vinkemeier (vinkemeier@fmp-berlin.de)
Thomas Meyer (meyer@fmp-berlin.de)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie, Robert-Rössle-Str. 10, 13125 Berlin, Germany.


Abstract

Interferon stimulation of cells can activate several hundred target genes, many of which are required for antiviral protection. Promoter binding of tyrosine-phosphorylated (activated) Stat1 dimers is essentiell for gene induction, a process that often entails the oligomerization of Stat1 dimers via interactions of their aminoterminal domains. The mutation of a single residue (F77) in the N-domain of Stat1 was recently demonstrated to preclude both the dephosphorylation and the oligomerization of Stat1 dimers. Here, we investigated the influence of defective oligomerization on a complex phenotype such as the induction of an antiviral state. It was found that the antiviral protection conferred by interferon-a was strongly reduced, whereas the interferon-g response was not measurably affected. These results indicate that Stat1 oligomerization is required for the antiviral activity of interferons. Moreover, the concentration of activated Stat1 in the nucleus may generally play a critical role for interferon-induced target gene activation.

[ Full-text PDF | Table of Contents ]


Japanese Society for Bioinformatics